<DOC>
	<DOCNO>NCT00899379</DOCNO>
	<brief_summary>A study evaluate rizatriptan treatment multiple attack acute migraine compare placebo .</brief_summary>
	<brief_title>Treatment Multiple Attacks Acute Migraine ( 0462-025 )</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>Patient least 6month history migraine , without aura Patient male , female must postmenopausal , surgically sterilize , take adequate contraceptive precaution . Patient judge good health , apart migraine Patient pregnant nursing mother . Patient abuse drug alcohol within 12 month prior enter study Patient history cardiovascular disease Patient clinically significant ECG abnormality Patient rest systolic blood pressure great 145 mm Hg diastolic le 95 mm Hg screening Patient receive treatment investigational device compound within 30 day study start Patient typically suffer less 1 8 attack migraine per month Patient difficulty distinguish his/her migraine attack tension interval headache Patient prior exposure rizatriptan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>